The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
October 9th 2024
Based off rapid magnetic resonance imaging (MRI), the AI-enabled MuscleView reportedly offers 3D analysis of muscle volume, muscle asymmetry and intramuscular fat.
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
CT, MR edge ultrasound in PVD utility, but CT wins on cost
March 5th 2006CT and MR angiography both provided more clinically useful information than duplex ultrasound in screening peripheral vascular disease. But when costs are factored in, CT emerged as the clear leader, according to a four-hospital study conducted in the Netherlands and described Saturday.
MR juggles obstacles, advantages in liver RFA guidance
March 5th 2006MR offers decided advantages as a tool for image guidance in radiofrequency ablation of liver tumors, but it also presents significant problems that must be overcome before its use becomes widespread, according to a pair of presentations March 5 at the European Congress of Radiology.
MR colonography evolves to meet screening needs
March 3rd 2006MR colonography has yet to capture radiologists’ imagination to the same extent as CT. But the radiation-free exam has a bright future, especially if stool tagging techniques can avoid the need for bowel cleansing, according to speakers from the U.S. and Greece at ECR on Friday.
Radiologists add value to multidisciplinary cancer team
March 2nd 2006As cancer is discovered earlier and therapy administered sooner, patients are living longer. The role of imaging in cancer is increasing, bringing radiologists closer to the heart of the multidisciplinary care team. A categorical course at the ECR explored this topic.
Imaging of shoulder opens new turf fight for radiologists
March 1st 2006Although musculoskeletal radiologists have long debated the relative roles of MRI and ultrasound in imaging shoulder injuries, they have reached consensus on a number of diagnostic algorithms. But the proliferation of inexpensive, low-end compact ultrasound systems has introduced a new controversy.
MSK radiologist questions shoulder ultrasound data
March 1st 2006After reviewing the clinical literature on ultrasound imaging of the shoulder, Dr. David Stoller, director of musculoskeletal MRI at the California Pacific Medical Center in San Francisco, concluded that a significant amount of data was either flawed or inaccurate.
Nuclear medicine society serves up online CME
March 1st 2006The Society of Nuclear Medicine's recently launched Lifelong Learning and Self-Assessment Program offers online modules to help physicians comply with new maintenance of certification requirements, including 20 nuclear medicine-specific CME credits every year.
'Mr. January' wears a Nobel medal
February 11th 2006This is one pinup calendar you probably won't find in your mechanic's garage. The "Big Brains on Campus" calendar features artistically enhanced MR brain scans of University of Illinois administrators, faculty, staff, and students. It serves as a promotion for the Beckman Institute for Advanced Science and Technology.
MR imaging evaluates ulcerative colitis cases
February 11th 2006Advances in MR technology have improved the quality of abdominal MRI and hence the ability to assess intestinal diseases. Rapid acquisition sequences have reduced the incidence of motion artifacts from intestinal peristalsis, while the use of phased-array coils has increased spatial resolution. Several intestinal contrast agents have undergone extensive trials. Meanwhile, the use of sequences that modulate MRI signal selectively, for example by suppressing fat tissue signal, can improve gadolinium-related enhancement on T1-weighted images, as well as boosting T2 signal in pathologic tissues.
MRA contrast selection expands with new compounds
February 11th 2006Contrast agents that can aid MRA examinations have been on the market for more than 15 years. Historically, radiologists could choose from a wide range of agents that, once injected intravenously, would flow through the extracellular space. They would then be excreted from the body relatively rapidly. These extracellular contrast agents are now being joined by a new class of blood pool, or intravascular, contrast agents that bind with molecules in the blood and stay in the circulation for longer.
Coronary MRA struggles against success of CTA
February 11th 2006The failure of MRA to make major inroads into coronary angiography is not due to lack of trying. Many different techniques have been attempted, often with encouraging results. Additional clinical trials, involving both healthy volunteers and patients, are ongoing. But promising research results in a controlled environment are no guarantee of clinical viability.
MRA evolves to meet changing clinical needs
February 11th 2006Contrast-enhanced MR angiography is the primary method of assessing vascular disease at many hospitals worldwide. While advances in technology ensure that CT angiography draws its share of devotees, MRA continues to win hearts and minds among radiologists who prefer the radiation-free imaging approach.
Vendors refine offerings to boost efficiency
February 11th 2006In the wake of the U.S. holiday of Thanksgiving every year, a city rises within the confines of Chicago's McCormick Place. It is a kind of radiological Epcot Center, a futuristic vision designed to dazzle; constructed of software, heavy iron, and handhelds; and swathed in platitudes.
Imaging offers insight into blood-brain permeability
February 11th 2006Neuroradiologists understand that high-grade tumors interrupt the blood-brain barrier, which presents as contrast enhancement on CT and MRI. Renewed interest in the phenomenon of permeability, however, has researchers looking beyond simple contrast enhancement and toward molecular mechanisms involved in permeability that may help them treat brain tumors more effectively.
Convert turf battles into productive joint ventures
February 11th 2006Since the introduction of cardiac catheterization in the 1940s, development and implementation of cardiovascular imaging techniques have been a collaborative effort among several specialties, particularly radiology and cardiology. Many pioneers in CV imaging have held joint appointments.
Poster prizewinners include controversial imaging agent
February 11th 2006On the same day that New York researchers received the top honor at the RSNA meeting for their poster detailing the benefits of an infection imaging agent, the drug's maker issued a warning about two deaths and additional serious adverse events attributed to the drug's use. The admonition was released by Tyco Mallinckrodt Healthcare, which markets NeutroSpec (technetium-99m fanolesomab), a monoclonal antibody-labeled radiopharmaceutical agent approved in the U.S. for the diagnosis of equivocal appendicitis.